Literature DB >> 25471518

Clinical pharmacology in Russia-historical development and current state.

Ksenia Zagorodnikova Goryachkina1, Aleksandra Burbello, Dmitry Sychev, Maxim Frolov, Vladimir Kukes, Vladimir Petrov.   

Abstract

Clinical pharmacology in Russia has long history and is currently active, but rather unrecognized internationally. It is governmentally approved as a teaching/scientific specialty since 1983 and as a medical specialty since 1997. Courses of clinical pharmacology are included in the undergraduate curricula in the 5th and/or 6th year of education at all medical schools in the Russian Federation. Postgraduate education includes initial specialization in internal medicine with further residency in clinical pharmacology. Governmental legislation recommends that every healthcare institution has either a department or a single position of clinical pharmacologist. Major routine duties include information about and monitoring of medication use, consultations in difficult clinical situations, pharmacogenetic counseling, therapeutic drug monitoring, pharmacovigilance, and participation in drug and therapeutics (formulary) committees. There are official experts in clinical pharmacology in Russia responsible for coordinating relevant legislative issues. The chief expert clinical pharmacologist represents the discipline directly at the Ministry of Health. Research in clinical pharmacology in Russia is extensive and variable, but only some of it is published internationally. Russia is a participant of international societies of clinical pharmacology and therapeutics and collaboration is actively ongoing. There are still certain problems related to the development of the discipline in Russia-some healthcare institutions do not see the need for clinical pharmacology. However, the number of clinical pharmacologists in Russia is increasing as well as their role in physicians' education, national healthcare, and research.

Entities:  

Mesh:

Year:  2014        PMID: 25471518     DOI: 10.1007/s00228-014-1787-6

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

1.  Towards a core curriculum in clinical pharmacology for undergraduate medical students in Europe.

Authors:  Michael Orme; Jurgen Frolich; Bozidar Vrhovac
Journal:  Eur J Clin Pharmacol       Date:  2002-11-20       Impact factor: 2.953

2.  Clinical pharmacology in research, teaching and health care: Considerations by IUPHAR, the International Union of Basic and Clinical Pharmacology.

Authors:  Donald Birkett; Kim Brøsen; Ingolf Cascorbi; Lars L Gustafsson; Simon Maxwell; Lembit Rago; Michael Rawlins; Marcus Reidenberg; Folke Sjöqvist; Tony Smith; Petra Thuerman; Andrew Walubo; Michael Orme; Folke Sjöqvist
Journal:  Basic Clin Pharmacol Toxicol       Date:  2010-07       Impact factor: 4.080

3.  The frequency of cytochrome P450 2C9 genetic variants in the Russian population and their associations with individual sensitivity to warfarin therapy.

Authors:  Sofya N Pchelina; Olga V Sirotkina; Anastasiya E Taraskina; Tatyana V Vavilova; Alexander L Shwarzman; Eugene I Schwartz
Journal:  Thromb Res       Date:  2005       Impact factor: 3.944

4.  Clinical Pharmacology in European health care-outcome of a questionnaire study in 31 countries.

Authors:  Michael Orme; Folke Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  2013-05-10       Impact factor: 2.953

Review 5.  Development of clinical pharmacology as a medical speciality in Europe - the roles of WHO, IUPHAR and EACPT.

Authors:  Folke Sjöqvist
Journal:  Basic Clin Pharmacol Toxicol       Date:  2014-06-21       Impact factor: 4.080

6.  [Anticoagulant action and safety of warfarin dosing based on pharmacogenetic testing: results of the first Russian prospective pilot study].

Authors:  D A Sychev; I M Antonov; I V Ignat'ev; Iu V Naumova; V A Dmitriev; E S Kropacheva; O B Dobrovol'skiĭ; E P Panchenko; I A Tashenova; V G Kukes
Journal:  Kardiologiia       Date:  2010       Impact factor: 0.395

7.  Personalized medicine: myth or reality? The position of Russian clinical pharmacologists.

Authors:  Anna S Zhestovskaja; Vladimir G Kukes; Dmitry A Sychev
Journal:  EPMA J       Date:  2013-05-11       Impact factor: 6.543

  7 in total
  2 in total

1.  An opportunity for clinical pharmacology trained physicians to improve patient drug safety: A retrospective analysis of adverse drug reactions in teenagers.

Authors:  Andy R Eugene; Beata Eugene
Journal:  F1000Res       Date:  2018-05-30

2.  Medication errors in hematology-oncology ward by consultation: The role of the clinical pharmacologist.

Authors:  Ali Eishy Oskuyi; Hamdolah Sharifi; Rahim Asghari
Journal:  Caspian J Intern Med       Date:  2021
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.